Clorox Needs to Deliver on Innovation, Execution, RBC Says

MT Newswires Live
02/05

Clorox's (CLX) recovery in H2 fiscal 2026 will depend on its ability to deliver results from its largest innovation slate in years and complete its ERP transition, RBC said in a note Wednesday.

The company is rolling out new products across multiple brands, including Hidden Valley and Scentiva, along with a relaunch of its cat litter line, which should begin to show benefits in late fiscal Q3 as shelf resets begin, the report said.

The ERP system upgrade, which went live last July, is expected to finish by the end of Q3, it added.

"2H'26 momentum and investor confidence into 2027 hinges on CLX's ability to execute on its initiatives," the report said.

RBC kept its sector perform rating while cutting its price target to $132 from $142 on the back of moderating long-term margin expansion and higher long-term capital expenditure.

Price: 117.17, Change: +2.19, Percent Change: +1.90

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10